PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry,...
-
Upload
jennifer-warren -
Category
Documents
-
view
217 -
download
0
Transcript of PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry,...
![Page 1: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/1.jpg)
PIPC® Psychiatry In Primary Care
MedicationsRobert K. Schneider, MD
Departments of Psychiatry, Internal Medicine
and Family Practice
The Medical College of Virginia at
the Virginia Commonwealth University
Richmond, Virginia
![Page 2: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/2.jpg)
PIPC® Goals
• Effectively recognize, diagnose and treat mental illness in primary care
• Bring the psychiatry skills and knowledge base of the primary care physician on par with other medical specialty knowledge bases
![Page 3: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/3.jpg)
Outline
• PIPC 1– Introduction
– PIPC® Interview– MAPS-O®
– Mood Disorders
– Suicide
![Page 4: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/4.jpg)
Outline
• PIPC 2– Anxiety Disorders
• PIPC 3– Neurotransmitters
– The 3 Phases and the 5Rs
– Medications
– Cases and Discussion
![Page 5: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/5.jpg)
NEUROTRANSMITTERS
![Page 6: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/6.jpg)
Decreased state due to up-regulation of receptors
Neurotransmitter Receptor Hypothesis Neurotransmitter Receptor Hypothesis of Antidepressant Actionof Antidepressant Action
6-2 Stahl S M, Essential Psychopharmacology (2000)
![Page 7: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/7.jpg)
6-5 6-6
Stahl S M, Essential Psychopharmacology (2000)
Antidepressant blocks the reuptake pump, causing more
NT to be in the synapse
Neurotransmitter Receptor Hypothesis Neurotransmitter Receptor Hypothesis of Antidepressant Actionof Antidepressant Action
Increase in NT causes receptors to down-regulate
![Page 8: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/8.jpg)
receptor sensitivity
6-1 Stahl S M, Essential Psychopharmacology (2000)
amount of NT
clinical effect
antidepressant introduced
![Page 9: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/9.jpg)
The 3 Phases and 5 Rs
• Acute
• Continuation
• Maintenance
• Response
• Remission
• Relapse
• Recovery
• Recurrence
![Page 10: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/10.jpg)
DEPRESSION
NORMAL MOOD
RECOVERY OR REMISSION
EPISODE OF DEPRESSIONEPISODE OF DEPRESSION
TIME6 - 24 months
5-1 Stahl S M, Essential Psychopharmacology (2000)
![Page 11: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/11.jpg)
acute 6 - 12 weeks
continuation4-9 months
maintenance1 or more years
REMISSION
RECOVERY
DEPRESSION
NORMAL MOOD
100%
5-3 Stahl S M, Essential Psychopharmacology (2000)
TIME
![Page 12: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/12.jpg)
5-4 Stahl S M, Essential Psychopharmacology (2000)
acute 6 - 12 weeks
continuation4-9 months
maintenance1 or more years
TIME
DEPRESSION
NORMAL MOOD RELAPSE RECURRENCE
![Page 13: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/13.jpg)
Acute Phase Treatment• Focus is response and full remission
• establish target symptoms
• patient preference, “collaborative approach”
• Psychotherapy especially helpful in chronic
depression or depression exacerbated by recent
stressors
• Acute phase is over ONLY after a remission is
achieved
![Page 14: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/14.jpg)
DEPRESSION
NORMAL MOOD
RESPONSE
RESPONSE
5-2 Stahl S M, Essential Psychopharmacology (2000)
![Page 15: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/15.jpg)
Changing the Medication• “Pseudoresistance”
– Verifying Compliance (“like an antibiotic”)– “Too little, too late”– Inadequate duration– Correct diagnosis (undetected comorbid diagnosis)
• Worsening Condition– severity escalating
– new symptoms developing (destructive impulses)
• Partial Remission vs. Full Remission
![Page 16: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/16.jpg)
Continuation Phase Treatment• Focus is to prevent relapse
• Period of time following full remission during
which discontinuation of treatment will result
in relapse
• Don’t stop before 6-9 months of therapy
• Don’t decrease the dosage
• Full Dosage, for the Full Period of Time
![Page 17: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/17.jpg)
5-4 Stahl S M, Essential Psychopharmacology (2000)
acute 6 - 12 weeks
continuation4-9 months
maintenance1 or more years
TIME
DEPRESSION
NORMAL MOOD RELAPSE RECURRENCE
![Page 18: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/18.jpg)
Maintenance Phase Treatment
• Focus is to prevent recurrence
• Recurrence can only occur after the
recovery from a previous episode
• Therefore only recurrent major
depression is considered
• Maintain Full Dosage
![Page 19: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/19.jpg)
Termination vs. Maintenance
• Degree of Functional Impairment
• Additional non-affective mental disorder
• Chronic medical disorder
• Prior history of depressive episode
1 episode: 50-80%
2 or more episodes: 80-90%
• Persistence of dysthymic symptoms
![Page 20: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/20.jpg)
5-4 Stahl S M, Essential Psychopharmacology (2000)
acute 6 - 12 weeks
continuation4-9 months
maintenance1 or more years
TIME
DEPRESSION
NORMAL MOOD RELAPSE RECURRENCE
![Page 21: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/21.jpg)
MEDICATIONS
![Page 22: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/22.jpg)
General Considerations
• Three Neurotransmitters– Serotonin– Norepinephrine– Dopamine
• Three major sites of action– Reuptake pump– Post-synaptic receptor– MAO enzyme inhibition
![Page 23: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/23.jpg)
Common Classes
• TCAD– NE and 5HT Reuptake inhibition
• SSRI– 5HT Reuptake inhibition
• “Less Selective” Reuptake inhibition– DA and NE (buproprion)– 5HT and NE (venlafaxime)
• Post synaptic receptor blockade– Trazodone, nafazodone
![Page 24: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/24.jpg)
Norepinephrine and Serotonin Reuptake Inhibitors: TCAD
• Classic Tricyclic Antidepressants–amitriptyline (Elavil)
–clomipramine (Anafranil)
–desipramine (Norpramin)
–imipramine (Tofranil)
–nortriptyline (Pamelor)
![Page 25: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/25.jpg)
Norepinephrine and Serotonin Reuptake Inhibitors: Effects
• Primarily blocks reuptake of norepinephrine, serotonin and weakly dopamine
• Effective in severe depression and anxiety disorders
• Sedating properties, reduces pain and stimulates appetite
• Nortriptyline level is a meaningful measurement
![Page 26: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/26.jpg)
Norepinephrine and Serotonin Reuptake Inhibitors
• Side Effects– urinary retention, constipation, blurred vision,
dry mouth, weight gain, sexual dysfunction
– orthostatic hypotension, delayed cardiac conduction
• Cautions– the elderly
– cardiac patients
![Page 27: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/27.jpg)
Selective Serotonin Reuptake Inhibitors
• Classic SSRIs
–sertraline (Zoloft)
–fluoxetine (Prozac)
–paroxetine (Paxil)
–citralopam (Celexa)
![Page 28: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/28.jpg)
Selective Serotonin Reuptake Inhibitors: Effects
• Selectively blocks the serotonin reuptake pump
• Mild to moderate depression (max doses in severe)
• Safer in overdose
• Indicated for anxiety disorders
![Page 29: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/29.jpg)
Selective Serotonin Reuptake Inhibitors: Side Effects• Side Effects
– nausea, headache– jitteriness and insomnia (especially early)– sexual dysfunction– “Discontinuation Syndrome”
• Cautions– very few – notable exception: Serotonin Syndrome
![Page 30: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/30.jpg)
Less Selective Reuptake Inhibitors
• Serotonin, Norepinephrine and mild
Dopamine Reuptake Inhibitor
–venlafaxine (Effexor)• Dopamine, Norepinephrine and mild
Serotonin Reuptake Inhibitor
–bupropion (Wellbutrin)
![Page 31: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/31.jpg)
Serotonin, Norepinephrine & Mild Dopamine Reuptake Inhibitor
• venlafaxine (Effexor)– Effects
• blocks reuptake of serotonin, norepinephrine and dopamine (mildly)
• antidepressant effects and anxiolytic properties
– Side Effects• nausea, somnolence, dry mouth, constipation,
nervousness, dizziness• risk of increased blood pressure
![Page 32: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/32.jpg)
Dopamine, Norepinephrine & Weak Serotonin Reuptake Inhibitor• bupropion (Wellbutrin)
– Effects• moderate dopamine reuptake inhibition,
norepinephrine reuptake inhibitor (bupropion metabolite), and weak serotonin reuptake inhibition
• antidepressant, antismoking, NOT ANXIOLYTIC– Side Effects
• agitation, tremor, insomnia, headache, constipation• increased risk of seizures at doses above 450mg/day• minimal sexual dysfunction, cardiac complications,
or weight gain– Cautions
• history of seizures or previous head trauma
![Page 33: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/33.jpg)
Postsynaptic Serotonin Inhibition
• Serotonin (postsynaptic 5HT-2 inhibition)– trazodone (Desyrel)– nafazodone (Serzone)
![Page 34: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/34.jpg)
Postsynaptic Serotonin Inhibition
• trazodone (Desyrel)– Effects
• sedating, good hypnotic• Post synaptic receptor blockade, weak SSRI
– Side Effects• difficult to get to high enough doses for depression• sedation, dry mouth, orthostasis, priapism (very rare)
• nafazodone (Serzone)– Effects
• effective antidepressant• good anxiolytic, effective in the anxious depressed• Post synaptic blockade, moderate SSRI
– Side Effects• sedation (much less than trazodone), nausea, visual
disturbances, lightheadedness
![Page 35: PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.](https://reader030.fdocuments.net/reader030/viewer/2022032709/56649eb75503460f94bc1892/html5/thumbnails/35.jpg)
CASES